Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study

Diabetes Care

Volumn 35, Issue 12, 2012, Pages 2540-2547

  Tabák, Adam G ^a,b   Carstensen, Maren ^c   Witte, Daniel R ^a,d   Brunner, Eric J ^a   Shipley, Martin J ^a   Jokela, Markus ^a,e   Roden, Michael ^c,f   Kivimäki, Mika ^a,e   Herder, Christian ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c HEINRICH HEINE UNIVERSITY   (Germany)

^d STENO DIABETES CENTER   (Denmark)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN;

ADULT; ARTICLE; BRITISH; COHORT ANALYSIS; CONTROLLED STUDY; DIABETOGENESIS; DISEASE COURSE; ETHNIC GROUP; FEMALE; FOLLOW UP; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ONSET AGE; POPULATION RESEARCH; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RISK FACTOR; SEX DIFFERENCE; TREND STUDY;

ADIPONECTIN; ADULT; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84869810917     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-2263     Document Type: Article

References (40)

1. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-89 (Pubitemid 36740452)
2. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 1995; 270:26746-26749
3. Ziemke F, Mantzoros CS. Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 2010;91: 258S-261S
4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553 (Pubitemid 28319935)
5. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009;373: 2215-2221
6. Fumeron F, Aubert R, Siddiq A, et al.; Epidemiologic Data on the Insulin Resistance Syndrome (DESIR) Study Group. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 2004;53:1150-1157 (Pubitemid 38436631)
7. Daimon M, Oizumi T, Saitoh T, et al.; Funagata study. Decreased serumlevels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study. Diabetes Care 2003;26:2015-2020 (Pubitemid 41184244)
8. Snijder MB, Heine RJ, Seidell JC, et al. Associations of adiponectin levels with incident impaired glucose metabolism and type 2 diabetes in older men and women: the hoorn study. Diabetes Care 2006;29:2498-2503 (Pubitemid 44912259)
9. Lindsay RS, Funahashi T, Hanson RL, et al. Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet 2002;360:57-58 (Pubitemid 34756495)
10. Mather KJ, Funahashi T, Matsuzawa Y, et al.; Diabetes Prevention Program. Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program. Diabetes 2008;57: 980-986
11. Spranger J, Kroke A, Möhlig M, et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet 2003;361:226-228 (Pubitemid 36126226)
12. Heidemann C, Sun Q, van Dam RM, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 2008;149:307-316
13. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and metaanalysis. JAMA 2009;302:179-188
14. Schwarz PE, Towers GW, Fischer S, et al. Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 2006;29:1645-1650 (Pubitemid 44127594)
15. Tabák AG, Brunner EJ, Miller MA, et al. Low serum adiponectin predicts 10-year risk of type 2 diabetes and HbA1c independently of obesity, lipids, and in- flammation: Whitehall II study. Horm Metab Res 2009;41:626-629
16. Carstensen M, Herder C, Kivimäki M, et al. Accelerated increase in serum interleukin-1 receptor antagonist starts 6 years before diagnosis of type 2 diabetes: Whitehall II prospective cohort study. Diabetes 2010;59:1222-1227
17. Esposito K, Pontillo A, Di Palo C, et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 2003;289:1799-1804 (Pubitemid 37430249)
18. Yamamoto Y, Hirose H, Saito I, Nishikai K, Saruta T. Adiponectin, an adipocyte-derived protein, predicts future insulin resistance: two-year follow-up study in Japanese population. J Clin Endocrinol Metab 2004;89:87-90 (Pubitemid 38183864)
19. Langenberg C, Bergstrom J, Laughlin GA, Barrett-Connor E. Ghrelin, adiponectin, and leptin do not predict long-term changes in weight and body mass index in older adults: longitudinal analysis of the Rancho Bernardo cohort. Am J Epidemiol 2005;162:1189-1197 (Pubitemid 41785913)
20. Okauchi Y, Kishida K, Funahashi T, et al. Changes in serum adiponectin concentrations correlate with changes in BMI, waist circumference, and estimated visceral fat area in middle-aged general population. Diabetes Care 2009;32:e122
21. Hotta K, Funahashi T, Bodkin NL, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50: 1126-1133 (Pubitemid 32374544)
22. Arawaka N, Daimon M, Oizumi T, et al. Correlation between change in body weight rather than current body weight and change in serum adiponectin levels in a Japanese population - the Funagata study. Metabolism 2006;55:324-330 (Pubitemid 43234385)
23. Marmot M, Brunner E. Cohort Profile: the Whitehall II study. Int J Epidemiol 2005; 34:251-256 (Pubitemid 40645308)
24. Wannamethee SG, Papacosta O, Lawlor DA, et al. Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. Diabetologia 2012;55:80-87
25. Ng MCY, Lee SC, Ko GTC, et al. Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity. Diabetes Care 2001;24:663-671 (Pubitemid 32888846)
26. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, et al. Prevalence and characteristics of early-onset type 2 diabetes in Mexico. Am J Med 2002;113:569-574 (Pubitemid 35379912)
27. Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 2001;24: 1522-1527 (Pubitemid 33716443)
28. Logue J, Walker JJ, Colhoun HM, et al.; Scottish Diabetes Research Network Epidemiology Group. Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia 2011;54:3003-3006
29. Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2006;84:427-433 (Pubitemid 44699156)
30. Heid IM, Henneman P, Hicks A, et al. Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 2010;208:412-420
31. Cook JR, Semple RK. Hypoadiponectinemia-cause or consequence of human "insulin resistance"? J Clin Endocrinol Metab 2010;95:1544-1554
32. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2006; 295:1288-1299
33. Ding EL, Song Y, Manson JE, et al. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med 2009;361:1152-1163
34. Perry JR, Weedon MN, Langenberg C, et al.; MAGIC. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Hum Mol Genet 2010;19:535-544
35. Liu Y, Retnakaran R, Hanley A, Tungtrongchitr R, Shaw C, Sweeney G. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects. J Clin Endocrinol Metab 2007; 92:4313-4318 (Pubitemid 350074750)
36. Duncan BB, Schmidt MI, Pankow JS, et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 2004;53: 2473-2478 (Pubitemid 39145606)
37. Koenig W, Khuseyinova N, Baumert J, Meisinger C, Löwel H. Serum concentrations of adiponectin and risk of type 2 diabetes mellitus and coronary heart disease in apparently healthy middle-aged men: results from the 18-year follow-up of a large cohort from southern Germany. J Am Coll Cardiol 2006;48:1369-1377 (Pubitemid 44436825)
38. Mente A, Razak F, Blankenberg S, et al.; Study of the Health Assessment And Risk Evaluation; Study of the Health Assessment And Risk Evaluation in Aboriginal Peoples Investigators. Ethnic variation in adiponectin and leptin levels and their association with adiposity and insulin resistance. Diabetes Care 2010;33:1629-1634
39. Jain SH, Massaro JM, Hoffmann U, et al. Cross-sectional associations between abdominal and thoracic adipose tissue compartments and adiponectin and resistin in the Framingham Heart Study. Diabetes Care 2009;32:903-908
40. Herder C, Hauner H, Haastert B, et al. Hypoadiponectinemia and proinflammatory state: two sides of the same coin?: results from the Cooperative Health Research in the Region of Augsburg Survey 4 (KORA S4). Diabetes Care 2006;29: 1626-1631 (Pubitemid 44127591)